| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |